Has Kristen Farraj received payments from drug or device companies?

Yes. Drug and device makers reported $4,998 in general payments to Kristen Farraj across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kristen Farraj did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kristen Farraj come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kristen Farraj

Gastroenterology · White Plains, NYNPI 1528529039

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 28.9% of the total.

$4,998in general payments, 2019–2025

Across 75 payments — averaging $66.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Madrigal Pharmaceuticals$604
Johnson & Johnson$541
Ipsen Biopharmaceuticals, Inc$471
Gilead$286
Lilly USA, LLC$286
plus $1K from 16 others

What the payments were for

Food & beverage$4,91398%
Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	16	$1,443
Madrigal Pharmaceuticals	6	$604
Johnson & Johnson	9	$541
Ipsen Biopharmaceuticals, Inc	9	$471
Gilead	6	$286
Lilly USA, LLC	4	$286
Phathom Pharmaceuticals, Inc.	3	$279
Mallinckrodt Hospital Products Inc.	3	$253
Sanofi	1	$148
Boston Scientific	2	$137
Celltrion USA Inc.	1	$125
Regeneron Healthcare Solutions, Inc.	3	$95
Fujifilm Healthcare Americas Corporation	1	$85
United Therapeutics Corporation	2	$62
QOL Medical, LLC	2	$57
Caris MPI, Inc.	1	$31
Intercept Pharmaceuticals, Inc.	1	$19
Urgo Medical North America, LLC	1	$18
Braintree Laboratories, Inc.	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$15
Exact Sciences	1	$14
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,998 in reported general payments places this provider in the 65th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	38	$334
Amitriptyline Hcl	12	$168
Atorvastatin Calcium	17	$130

Paid to pharmacies, not to this prescriber.

Other gastroenterology in White Plains

David Carr LockeNew York$2M
Arthur KornbluthNew York$1.9M
Maya SrivastavaWilliamsville$1.8M
Melissa PalmerPlainview$1M
Sonal KumarNew York$1M
David PoppersNew York$939K
Ellen ScherlNew York$857K
Bruce SandsNew York$810K
Jean Frederick ColombelNew York$786K
Seth GrossNew York$624K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →